BioE Seminar: Seek, Destroy and Heal: Enzyme-Responsive Nanoparticles as In Vivo Targeted Delivery Systems

Oct 5

Thursday, October 5, 2017

12:00 pm - 1:00 pm
Fitzpatrick Center Schiciano Auditorium Side B

Presenter

Nathan Gianneschi - Professor of Chemistry, Materials Science & Engineering, and Biomedical Engineering, Northwestern University

Abstract: The goal of targeted therapeutics and molecular diagnostics is to accumulate drugs or probes at the site of disease in higher quantities relative to other locations in the body. To achieve this, there is tremendous interest in the development of nanomaterials capable of acting as carriers or reservoirs of therapeutics and diagnostics in vivo.[1] Generally, nanoscale particles are favored for this task as they can be large enough to function as carriers of multiple copies of a given small molecule, can display multiple targeting functionalities, and can be small enough to be safely injected into the blood stream. The general goal is that particles will either target passively via the enhanced permeability and retention (EPR) effect, actively by incorporation of targeting groups, or by a combination of both.[2] Nanoparticle targeting strategies have largely relied on the use of surface conjugated ligands designed to bind overexpressed cell-membrane receptors associated with a given cell-type.[3] We envisioned a targeting strategy that would lead to an active accumulation of nanoparticles by virtue of a supramolecular assembly event specific to tumor tissue, occurring in response to a specific signal. The most desirable approach to stimuli-induced targeting would be to utilize an endogenous signal, specific to the diseased tissue itself, capable of actively targeting materials introduced via intravenous (IV) injection.

Add to calendar

Contact

King, Pamela
919-660-5335
pamela.king@duke.edu

More Information